synapcyte blog

Keeping up with a field that keeps changing.

Emerging methods in life science, written for the person deciding whether to use one: what it measures, what it costs, and when the cheaper option answers the same question.

Sep 1, 2026 · 11 min read
How to analyse NGS data, start to finish
A practical order of operations for RNA-seq, including the two decisions made before the sequencer runs that no amount of careful processing can fix, and why you probably should not trim your reads.
Read more →
Aug 27, 2026 · 8 min read
Organoids and the animal-model shift: what changed, and what it means for your study design
FDA guidance moved further in eighteen months than in the previous twenty years, including a detail most coverage missed: NAMs need neither validation nor qualification to support an application. What that does and does not mean for an academic lab.
Read more →
Aug 13, 2026 · 7 min read
AI protein design: what you can actually commission today
De novo binder design works now, at hit rates that make small campaigns viable. BindCraft reports 30.7% overall across 212 designs, ranging from 10% to 60% depending only on the target. What that means if you want to try it.
Read more →
Jul 30, 2026 · 8 min read
Spatial transcriptomics: which platform, and do you actually need single-cell resolution?
Visium HD, Xenium, CosMx and MERSCOPE answer the same three-way trade-off differently. What the published benchmarks really say, what the platforms cost, and when plain scRNA-seq answers your question for a fraction of the price.
Read more →
Jul 16, 2026 · 6 min read
Academia drives the science. No single lab can build all of it.
Every technique defining the frontier of biology started in an academic lab. That same turnover means the toolset a competitive lab needs now grows faster than any lab can acquire it, which makes access, not ideas, the real constraint.
Read more →

New posts, straight to your inbox

Emerging methods in life science, no more than one email a week. No hype, and we say when something is not worth it.

Keeping up with a field that keeps changing.

How to analyse NGS data, start to finish

Organoids and the animal-model shift: what changed, and what it means for your study design

AI protein design: what you can actually commission today

Spatial transcriptomics: which platform, and do you actually need single-cell resolution?

Academia drives the science. No single lab can build all of it.

New posts, straight to your inbox